Screener
Pacira BioSciences, Inc. PCRX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
FAQ
- What is Pacira BioSciences, Inc.'s enterprise value?
- Pacira BioSciences, Inc. (PCRX) reported enterprise value of $1.18B in Q1 2026.
- How has Pacira BioSciences, Inc.'s enterprise value changed year-over-year?
- Pacira BioSciences, Inc.'s enterprise value decreased by 3.4% year-over-year, from $1.22B to $1.18B.
- What is the long-term trend for Pacira BioSciences, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s enterprise value has grown at a -13.2% compound annual growth rate (CAGR), from $2.79B to $1.37B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Pacira BioSciences, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude